# Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism

> **NCT00937820** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 87 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** YM150

## Key facts

- **NCT ID:** NCT00937820
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2011-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00937820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00937820, "Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00937820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*